Publications by authors named "Ralph Torgler"

Claim this Profile
M
Mpox: Exploring Epidemiology, Disease Outcomes, and Preventative Vaccination Among People with HIV During the Ongoing Outbreaks.
Chloe Orkin, Ralph Torgler, Rebecca Dawson, Ian W Holloway, Christian Hoffmann

Viruses· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast-Track to Protection? A Review of Encepur's Express Dosing Schedule for Tick-Borne Encephalitis.
Kyra Zens, Ralph Torgler, Michael Horn, Carsten Schade Larsen

Viruses· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What makes patients tick? Vaccine preferences against tick-borne encephalitis in four European countries.
Charlotta Zacharias, Ralph Torgler, Jennifer Cummins

BMC Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for a 10-year TBE vaccine booster interval: an evaluation of current data.
Jörg Schelling, Suzanne Einmahl, Ralph Torgler, Carsten Schade Larsen

Expert Rev Vaccines· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot Sub-Study of the Effect of Hepatitis C Cure by Glecaprevir/Pibrentasvir on the Gut Microbiome of Patients with Chronic Hepatitis C Genotypes 1 to 6 in the Mythen Study.
Bahtiyar Yilmaz, Lisa Ruckstuhl, Beat Müllhaupt, Lorenzo Magenta, Melanie Harrer Kuster, Ralph Torgler

Pharmaceuticals (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland.
Beat Müllhaupt, David Semela, Lisa Ruckstuhl, Lorenzo Magenta, Olivier Clerc, Ralph Torgler

Swiss Med Wkly· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, multicenter, post-marketing observational study to measure the quality of life of HCV genotype 1 infected, treatment naïve patients suffering from fatigue and receiving 3D regimen: The HEMATITE study.
Nasser Semmo, Beat Müllhaupt, Lisa Ruckstuhl, Lorenzo Magenta, Olivier Clerc, Ralph Torgler

PLoS One· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity.
Silayuv E Bongfen, Patricia M Ntsama, Sandra Offner, Thomas Smith, Ingrid Felger, Ralph Torgler

Vaccine· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sporozoite-mediated hepatocyte wounding limits Plasmodium parasite development via MyD88-mediated NF-kappa B activation and inducible NO synthase expression.
Ralph Torgler, Silayuv E Bongfen, Jackeline C Romero, Aubry Tardivel, Margot Thome

J Immunol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasmodium berghei-infected primary hepatocytes process and present the circumsporozoite protein to specific CD8+ T cells in vitro.
Silayuv E Bongfen, Ralph Torgler, Jackeline F Romero, Laurent Renia, Giampietro Corradin

J Immunol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality.
Nadia Corazza, Sabine Jakob, Corinne Schaer, Steffen Frese, Adrian Keogh, Ralph Torgler

J Clin Invest· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of activation-induced Fas (CD95/Apo-1) ligand expression in T cells by the cyclin B1/Cdk1 complex.
Ralph Torgler, Sabine Jakob, Edgar Ontsouka, Ulrich Nachbur, Christoph Mueller

J Biol Chem· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
Zoltan Wiener, Edgar C Ontsouka, Sabine Jakob, Ralph Torgler, Andras Falus

Exp Cell Res· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis